Intelence Articles
Two UK product launches
16 January 2012
Setback for Merck & Co as vicriviroc disappoints in Ph III
22 January 2010
Intelence submitted for full US approval
16 February 2009
J&J R&D chief calls for "open innovation"
16 February 2009
Emergency listing of HIV drugs in Japan
26 January 2009
PDCO meeting sees good news for J&J but a mix for GSK and AZ; Janssen pulls Invega app
12 January 2009
EC approves J&J's Intelence
8 September 2008
Thomson releases Pharma Matters reports for 1st qtr
1 September 2008
US FDA set for even fewer approvals in 2008
1 September 2008
CHMP gives go ahead to Tibotec's novel NNRTI
7 July 2008
Tibotec's Intelence cuts HIV load at 48 weeks
18 February 2008
Showing 1-13 of 13 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
